• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估生物可吸收血管支架装置植入后行为的方法。

Methods to assess bioresorbable vascular scaffold devices behaviour after implantation.

作者信息

Pernigotti Alberto, Moscarella Elisabetta, Spitaleri Giosafat, Scardino Claudia, Ishida Kohki, Brugaletta Salvatore

机构信息

Hospital Clinic, Institut Clinic Cardiovascular, IDIBAPS, Barcelona, Spain.

出版信息

J Thorac Dis. 2017 Aug;9(Suppl 9):S959-S968. doi: 10.21037/jtd.2017.06.110.

DOI:10.21037/jtd.2017.06.110
PMID:28894602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5583089/
Abstract

Bioresorbable vascular scaffolds (BRS) represent a novel approach for coronary revascularization offering several advantages as compared to current generation DES, potentially reducing rate of late adverse events and avoiding permanent vessel caging. Nevertheless, safety concerns have been raised for an increased risk of scaffold thrombosis (ScT) in both early and late phases, probably related to a suboptimal scaffold implantation. In this context, the use of different imaging methodologies has been strongly suggested in order to guarantee an optimal implantation. We herein analyze the different imaging methodologies available to assess BRS after implantation and at follow-up.

摘要

生物可吸收血管支架(BRS)是一种用于冠状动脉血运重建的新方法,与当代药物洗脱支架(DES)相比具有诸多优势,有可能降低晚期不良事件的发生率并避免血管永久性置入。然而,人们对早期和晚期支架内血栓形成(ScT)风险增加的安全性问题表示担忧,这可能与支架植入不理想有关。在这种情况下,强烈建议使用不同的成像方法以确保最佳植入效果。我们在此分析了可用于评估植入后及随访期BRS的不同成像方法。

相似文献

1
Methods to assess bioresorbable vascular scaffold devices behaviour after implantation.评估生物可吸收血管支架装置植入后行为的方法。
J Thorac Dis. 2017 Aug;9(Suppl 9):S959-S968. doi: 10.21037/jtd.2017.06.110.
2
A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.一种新一代生物可吸收冠状动脉支架系统:从实验室到首次临床评估:6 个月和 12 个月的临床和多模态影像学结果。
JACC Cardiovasc Interv. 2014 Jan;7(1):89-99. doi: 10.1016/j.jcin.2013.07.007. Epub 2013 Oct 16.
3
Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.经全吸收聚合物雷帕霉素洗脱支架冠状动脉植入治疗初发冠状动脉疾病患者的 5 年临床和功能多层螺旋 CT 血管造影结果:ABSORB 队列 A 试验。
JACC Cardiovasc Interv. 2013 Oct;6(10):999-1009. doi: 10.1016/j.jcin.2013.05.017.
4
Bioresorbable polymeric scaffolds for coronary revascularization: Lessons learnt from ABSORB III, ABSORB China, and ABSORB Japan.用于冠状动脉血运重建的生物可吸收聚合物支架:从ABSORB III、中国ABSORB及日本ABSORB研究中获得的经验教训
Glob Cardiol Sci Pract. 2015 Dec 22;2015(5):62. doi: 10.5339/gcsp.2015.62. eCollection 2015.
5
Invasive Imaging of Bioresorbable Coronary Scaffolds - A Review.生物可吸收冠状动脉支架的侵入性成像——综述
Interv Cardiol. 2013 Mar;8(1):23-35. doi: 10.15420/icr.2013.8.1.23.
6
IVUS-Guided Implantation of Bioresorbable Vascular Scaffolds for Very Late Paclitaxel Stent Thrombosis.血管内超声引导下生物可吸收血管支架植入治疗极晚期紫杉醇支架血栓形成
Acta Cardiol Sin. 2017 Jan;33(1):92-95. doi: 10.6515/acs20160328a.
7
Optical coherence tomography guidance during bioresorbable vascular scaffold implantation.生物可吸收血管支架植入术中的光学相干断层扫描引导
J Thorac Dis. 2017 Aug;9(Suppl 9):S986-S993. doi: 10.21037/jtd.2017.07.111.
8
Randomized Comparison of Absorb Bioresorbable Vascular Scaffold and Mirage Microfiber Sirolimus-Eluting Scaffold Using Multimodality Imaging.随机比较 Absorb 生物可吸收血管支架和 Mirage 微纤维西罗莫司洗脱支架的多模式影像学研究。
JACC Cardiovasc Interv. 2017 Jun 12;10(11):1115-1130. doi: 10.1016/j.jcin.2017.03.015. Epub 2017 May 17.
9
Major coronary evaginations following implantation of bioresorbable vascular scaffolds - Clinical and OCT characteristics.生物可吸收血管支架植入术后的主要冠状动脉突出——临床及光学相干断层扫描特征
Cardiovasc Revasc Med. 2019 Jun;20(6):485-491. doi: 10.1016/j.carrev.2018.08.001. Epub 2018 Aug 4.
10
Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months.依维莫司洗脱可吸收生物可降解血管支架植入后血管壁变化的动态研究:一项在6个月、12个月、24个月和36个月时进行的多成像模态研究
EuroIntervention. 2014 Mar 20;9(11):1271-84. doi: 10.4244/EIJV9I11A217.

引用本文的文献

1
Bioresorbable Magnesium-Based Stent: Real-World Clinical Experience and Feasibility of Follow-Up by Coronary Computed Tomography: A New Window to Look at New Scaffolds.生物可吸收镁基支架:真实世界临床经验及冠状动脉计算机断层扫描随访的可行性:观察新型支架的新窗口
Biomedicines. 2023 Apr 11;11(4):1150. doi: 10.3390/biomedicines11041150.
2
Imaging during percutaneous coronary intervention for optimizing outcomes.经皮冠状动脉介入治疗期间的成像以优化治疗结果。
Indian Heart J. 2018 Dec;70 Suppl 3(Suppl 3):S456-S465. doi: 10.1016/j.ihj.2018.08.012. Epub 2018 Aug 18.

本文引用的文献

1
Follow-up of coronary artery patency after implantation of bioresorbable coronary scaffolds: The emerging role of magnetic coronary artery imaging.生物可吸收冠状动脉支架植入术后冠状动脉通畅情况的随访:磁性冠状动脉成像的新作用
Cardiovasc Revasc Med. 2017 Jul-Aug;18(5):369-373. doi: 10.1016/j.carrev.2017.02.003. Epub 2017 Feb 7.
2
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score.在接受依维莫司洗脱生物可吸收支架植入术的患者中进行预扩张、尺寸测量和扩张后评分以预测心脏不良事件:PSP评分的开发与内部验证
EuroIntervention. 2017 Apr 20;12(17):2110-2117. doi: 10.4244/EIJ-D-16-00974.
3
Rationale and design of the East-West late lumen loss study: Comparison of late lumen loss between Eastern and Western drug-eluting stent study cohorts.东西方晚期管腔丢失研究的原理与设计:东西方药物洗脱支架研究队列晚期管腔丢失的比较
Am Heart J. 2016 Dec;182:103-110. doi: 10.1016/j.ahj.2016.07.011. Epub 2016 Aug 3.
4
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial.对比依维莫司洗脱生物可吸收支架与依维莫司洗脱金属支架治疗冠状动脉狭窄的疗效(ABSORB II):3 年随机、对照、单盲、多中心临床试验。
Lancet. 2016 Nov 19;388(10059):2479-2491. doi: 10.1016/S0140-6736(16)32050-5. Epub 2016 Oct 30.
5
[Absorb BVS: quo vadis?].[可吸收生物可降解支架:何去何从?]
G Ital Cardiol (Rome). 2016 Oct;17(10 Suppl 1):45S-46. doi: 10.1714/2372.25482.
6
[SICI-GISE Position paper: Use of Absorb BVS in clinical practice].[SICI-GISE立场文件:生物可吸收血管支架在临床实践中的应用]
G Ital Cardiol (Rome). 2016 Oct;17(10 Suppl 1):28S-44. doi: 10.1714/2372.25480.
7
Absorb vs. DESolve: an optical coherence tomography comparison of acute mechanical performances.吸收与溶解:急性机械性能的光学相干断层扫描比较。
EuroIntervention. 2016 Aug 5;12(5):e566-73. doi: 10.4244/EIJV12I5A96.
8
Acute stent recoil and optimal balloon inflation strategy: an experimental study using real-time optical coherence tomography.急性支架回缩与最佳球囊膨胀策略:一项使用实时光学相干断层扫描的实验研究
EuroIntervention. 2016 Jun 12;12(2):e190-8. doi: 10.4244/EIJV12I2A32.
9
The Impact of Post-Procedural Asymmetry, Expansion, and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial.在 ABSORB II 试验中,生物可吸收依维莫司洗脱支架和金属依维莫司洗脱支架的术后对称性、扩张和偏心对临床结果的影响。
JACC Cardiovasc Interv. 2016 Jun 27;9(12):1231-1242. doi: 10.1016/j.jcin.2016.03.027. Epub 2016 Jun 1.
10
Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial.第二代药物洗脱可吸收金属支架在初发冠状动脉病变患者中的持续安全性和性能:BIOSOLVE-II首次人体试验的12个月临床结果和血管造影结果
Eur Heart J. 2016 Sep 14;37(35):2701-9. doi: 10.1093/eurheartj/ehw196. Epub 2016 May 17.